198 related articles for article (PubMed ID: 20689437)
1. Immunosuppression in the sensitized heart transplant recipient.
Eckman PM
Curr Opin Organ Transplant; 2010 Oct; 15(5):650-6. PubMed ID: 20689437
[TBL] [Abstract][Full Text] [Related]
2. Desensitization and heart transplantation of a patient with high levels of donor-reactive anti-human leukocyte antigen antibodies.
Bućin D; Gustafsson R; Ekmehag B; Kornhall B; Algotsson L; Lund U; Otto G; Koul B
Transplantation; 2010 Dec; 90(11):1220-5. PubMed ID: 20885338
[TBL] [Abstract][Full Text] [Related]
3. Combined heart and liver transplantation: protection of the cardiac graft from antibody rejection by initial liver implantation.
Daly RC; Topilsky Y; Joyce L; Hasin T; Gandhi M; Rosen C; Heimbach J; Edwards BS; Pereira N; Stulak JM; Arendt CJ; Park SJ; Kushwaha SS
Transplantation; 2013 Jan; 95(2):e2-4. PubMed ID: 23325010
[No Abstract] [Full Text] [Related]
4. Sensitisation and post-transplant course after the implantation of ventricular assist device.
Malickaite R; Rucinskas K; Staneviciene A; Miniauskas S; Maneikiene V; Zuoziene G; Sirvydis V
Interact Cardiovasc Thorac Surg; 2009 Mar; 8(3):339-42; discussion 342-3. PubMed ID: 19098066
[TBL] [Abstract][Full Text] [Related]
5. Desensitization in the Setting of HLA-Incompatible Kidney Transplant.
Malvezzi P; Jouve T; Noble J; Rostaing L
Exp Clin Transplant; 2018 Aug; 16(4):367-375. PubMed ID: 29863455
[TBL] [Abstract][Full Text] [Related]
6. APRIL/BLyS Blockade Reduces Donor-specific Antibodies in Allosensitized Mice.
Wilson NA; Bath NM; Verhoven BM; Ding X; Boldt BA; Sukhwal A; Zhong W; Panzer SE; Redfield RR
Transplantation; 2019 Jul; 103(7):1372-1384. PubMed ID: 30830041
[TBL] [Abstract][Full Text] [Related]
7. SAHA, an HDAC inhibitor, attenuates antibody-mediated allograft rejection.
Zhang X; Guo M; Kang Y; Liu F; Zheng X; Han S; Fu S; Hong S; Ding G; Wang L; Wang QX
Transplantation; 2013 Sep; 96(6):529-37. PubMed ID: 23912176
[TBL] [Abstract][Full Text] [Related]
8. The effect of a positive B cell crossmatch on early rejection in cardiac transplant recipients.
Bunke M; Ganzel B; Klein JB; Oldfather J
Transplantation; 1993 Dec; 56(6):1595-7. PubMed ID: 8279050
[No Abstract] [Full Text] [Related]
9. Successful immunomodulation with intravenous gamma globulin and cyclophosphamide in an alloimmunized heart transplant recipient.
De Marco T; Damon LE; Colombe B; Keith F; Chatterjee K; Garovoy MR
J Heart Lung Transplant; 1997 Mar; 16(3):360-5. PubMed ID: 9087880
[TBL] [Abstract][Full Text] [Related]
10. Renal transplant allocation criteria, desensitization strategies and immunosuppressive therapy in retransplant renal patients.
Salvadori M; Bertoni E
J Nephrol; 2012; 25(6):890-9. PubMed ID: 22972671
[TBL] [Abstract][Full Text] [Related]
11. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
Herzberg GZ; Rossi AF; Courtney M; Gelb BD
J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
[TBL] [Abstract][Full Text] [Related]
12. Living donor kidney transplantation across positive crossmatch: the University of Illinois at Chicago experience.
Thielke JJ; West-Thielke PM; Herren HL; Bareato U; Ommert T; Vidanovic V; Campbell-Lee SA; Tzvetanov IG; Sankary HN; Kaplan B; Benedetti E; Oberholzer J
Transplantation; 2009 Jan; 87(2):268-73. PubMed ID: 19155983
[TBL] [Abstract][Full Text] [Related]
13. [HLA-incompatibility and kidney transplant: a question of desensitization].
Grosjean F
G Ital Nefrol; 2011; 28(6):581. PubMed ID: 22167608
[No Abstract] [Full Text] [Related]
14. Heart transplantation in a highly sensitised patient.
Hošková L; Pagáč ová L; Slavč ev A; Voska L; Kautzner J
Kardiol Pol; 2011; 69(1):51-3. PubMed ID: 21267967
[TBL] [Abstract][Full Text] [Related]
15. Renal transplantation in patients with positive lymphocytotoxicity crossmatches: one center's experience.
Magee CC; Felgueiras J; Tinckam K; Malek S; Mah H; Tullius S
Transplantation; 2008 Jul; 86(1):96-103. PubMed ID: 18622284
[TBL] [Abstract][Full Text] [Related]
16. Renal transplantation with B cell-positive crossmatch.
Mishra MN; Saxena VK
Saudi J Kidney Dis Transpl; 2012 Sep; 23(5):1077-9. PubMed ID: 22982930
[No Abstract] [Full Text] [Related]
17. Drug therapy in the heart transplant recipient: part I: cardiac rejection and immunosuppressive drugs.
Lindenfeld J; Miller GG; Shakar SF; Zolty R; Lowes BD; Wolfel EE; Mestroni L; Page RL; Kobashigawa J
Circulation; 2004 Dec; 110(24):3734-40. PubMed ID: 15596559
[No Abstract] [Full Text] [Related]
18. The current trend of induction and maintenance treatment in patient of different PRA levels: a report on OPTN/UNOS Kidney Transplant Registry data.
Cai J; Terasaki PI
Clin Transpl; 2010; ():45-52. PubMed ID: 21696031
[TBL] [Abstract][Full Text] [Related]
19. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
[TBL] [Abstract][Full Text] [Related]
20. The alloantibody network following intrathymic immunomodulation of sensitized rat recipients of cardiac allografts.
Binder J; Hancock WW; Watschinger B; Wasowska B; Sayegh MH; Kupiec-Weglinski JW
Transplantation; 1995 Feb; 59(4):590-7. PubMed ID: 7878763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
